Accelerator mass spectrometry-enabled studies: current status and future prospects.
about
Opportunities in low-level radiocarbon microtracing: applications and new technologyQuantifying exploratory low dose compounds in humans with AMS.Bioanalytical aspects of clinical mass balance studies in oncology.Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials.Preclinical in vivo ADME studies in drug development: a critical review.Soft-landing preparative mass spectrometry.Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.Application of a tiered approach to the validation of accelerator MS assays.Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review.Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach.Pharmacokinetics and metabolism of [14C]-tozadenant (SYN-115), a novel A2a receptor antagonist ligand, in healthy volunteers.Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS.Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences.Assessment of the absorption, metabolism and excretion of [¹⁴C]pasireotide in healthy volunteers using accelerator mass spectrometry.
P2860
Q28817904-C760A18F-CFCA-47FF-B01D-4469BDF62A28Q34708648-DC7B8A7E-BD44-4BA2-B30D-159F1DEE5553Q37963912-D945343C-938A-4362-8914-AB1B18D8E792Q37964571-6995608B-3C4C-465F-B8FC-C866BD0108A0Q37976124-0F8FE865-3525-42C7-9D37-9A6C2899D8A6Q38035314-191578BA-6280-4808-9AEC-69E4B6B68D49Q38102700-83B7E95C-4594-4954-8266-7D7F567BC081Q38195301-2FDD3D72-5631-47C9-80FB-3728B583CBD5Q38836158-3AF8A45C-4E8C-481B-9D4E-C32CEF01BF80Q38937832-FB12CA98-885B-4C31-9991-370C860A609CQ41265603-FC4CB1D4-796F-4BC4-8FB2-FD0F915044DEQ46506500-7450643B-85D0-4CF4-9CF2-38669A456D44Q47194002-5743FDB5-028F-4AD8-8C72-4B33DF186A68Q48225243-C8715DE5-21B9-48FA-898E-0D4BBF7CE8BEQ50988023-876E792A-85ED-44E2-90B2-AA6F6BBDF666
P2860
Accelerator mass spectrometry-enabled studies: current status and future prospects.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@ast
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@en
type
label
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@ast
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@en
prefLabel
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@ast
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@en
P2860
P356
P1433
P1476
Accelerator mass spectrometry-enabled studies: current status and future prospects.
@en
P2093
Ali Arjomand
P2860
P304
P356
10.4155/BIO.09.188
P577
2010-03-01T00:00:00Z